Verheul HMW - Search Results

1

Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection.

Bachas C, Hodzic J, van der Mijn JC, Stoepker C, Verheul HMW, Wolthuis RMF, Felley-Bosco E, van Wieringen WN, van Beusechem VW, Brakenhoff RH, de Menezes RX. Bachas C, et al. Among authors: verheul hmw. BMC Bioinformatics. 2018 Aug 20;19(1):301. doi: 10.1186/s12859-018-2306-z. BMC Bioinformatics. 2018. PMID: 30126372 Free PMC article.

2

Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer.

Buffart TE, Carvalho B, van Grieken NC, van Wieringen WN, Tijssen M, Kranenbarg EM, Verheul HM, Grabsch HI, Ylstra B, van de Velde CJ, Meijer GA. Buffart TE, et al. Oncologist. 2012;17(5):653-62. doi: 10.1634/theoncologist.2010-0379. Epub 2012 Apr 24. Oncologist. 2012. PMID: 22531355 Free PMC article.

3

Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin.

Posthumadeboer J, van Egmond PW, Helder MN, de Menezes RX, Cleton-Jansen AM, Beliën JA, Verheul HM, van Royen BJ, Kaspers GJ, van Beusechem VW. Posthumadeboer J, et al. Oncotarget. 2012 Oct;3(10):1169-81. doi: 10.18632/oncotarget.600. Oncotarget. 2012. PMID: 23045411 Free PMC article.

4

ShrinkBayes: a versatile R-package for analysis of count-based sequencing data in complex study designs.

van de Wiel MA, Neerincx M, Buffart TE, Sie D, Verheul HM. van de Wiel MA, et al. BMC Bioinformatics. 2014 Apr 26;15:116. doi: 10.1186/1471-2105-15-116. BMC Bioinformatics. 2014. PMID: 24766777 Free PMC article.

5

Mass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignancies.

Labots M, Schütte LM, van der Mijn JC, Pham TV, Jiménez CR, Verheul HM. Labots M, et al. Oncologist. 2014 Oct;19(10):1028-39. doi: 10.1634/theoncologist.2014-0101. Epub 2014 Sep 3. Oncologist. 2014. PMID: 25187478 Free PMC article. Review.

6

Predictive biomarkers in renal cell cancer: insights in drug resistance mechanisms.

van der Mijn JC, Mier JW, Broxterman HJ, Verheul HM. van der Mijn JC, et al. Drug Resist Updat. 2014 Oct-Dec;17(4-6):77-88. doi: 10.1016/j.drup.2014.10.003. Epub 2014 Oct 7. Drug Resist Updat. 2014. PMID: 25457974 Review.

7

Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer.

van der Mijn JC, Sol N, Mellema W, Jimenez CR, Piersma SR, Dekker H, Schutte LM, Smit EF, Broxterman HJ, Skog J, Tannous BA, Wurdinger T, Verheul HM. van der Mijn JC, et al. J Extracell Vesicles. 2014 Dec 8;3:25657. doi: 10.3402/jev.v3.25657. eCollection 2014. J Extracell Vesicles. 2014. PMID: 25491250 Free PMC article.

8

Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics.

van der Mijn JC, Labots M, Piersma SR, Pham TV, Knol JC, Broxterman HJ, Verheul HM, Jiménez CR. van der Mijn JC, et al. J Proteomics. 2015 Sep 8;127(Pt B):259-63. doi: 10.1016/j.jprot.2015.04.006. Epub 2015 Apr 16. J Proteomics. 2015. PMID: 25890253

9

Sunitinib activates Axl signaling in renal cell cancer.

van der Mijn JC, Broxterman HJ, Knol JC, Piersma SR, De Haas RR, Dekker H, Pham TV, Van Beusechem VW, Halmos B, Mier JW, Jiménez CR, Verheul HM. van der Mijn JC, et al. Int J Cancer. 2016 Jun 15;138(12):3002-10. doi: 10.1002/ijc.30022. Epub 2016 Mar 1. Int J Cancer. 2016. PMID: 26815723

10

Novel drugs that target the metabolic reprogramming in renal cell cancer.

van der Mijn JC, Panka DJ, Geissler AK, Verheul HM, Mier JW. van der Mijn JC, et al. Cancer Metab. 2016 Jul 13;4:14. doi: 10.1186/s40170-016-0154-8. eCollection 2016. Cancer Metab. 2016. PMID: 27418963 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters